apramycin   Click here for help

GtoPdb Ligand ID: 10760

Synonyms: EBL-1003 | EL-857 | EL857 | nebramycin factor 2 | nebramycin II
PDB Ligand
Comment: Apramycin is an aminoglycoside antibacterial compound that was originally isolated from Streptomyces tenebrarius. The compound has activity against Gram-negative bacteria [2,4].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 16
Hydrogen bond donors 11
Rotatable bonds 6
Topological polar surface area 283.64
Molecular weight 539.28
XLogP -4.99
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN[C@@H]1[C@H](O[C@@H]2[C@@H]([C@@H]1O)O[C@@H]([C@@H](C2)N)O[C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O[C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)N
Isomeric SMILES CN[C@@H]1[C@H](O[C@@H]2[C@@H]([C@@H]1O)O[C@@H]([C@@H](C2)N)O[C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O[C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)N
InChI InChI=1S/C21H41N5O11/c1-26-11-14(30)18-8(33-20(11)37-21-16(32)13(29)10(25)9(4-27)34-21)3-7(24)19(36-18)35-17-6(23)2-5(22)12(28)15(17)31/h5-21,26-32H,2-4,22-25H2,1H3/t5-,6+,7-,8+,9-,10-,11+,12+,13+,14-,15-,16-,17-,18+,19+,20-,21-/m1/s1
InChI Key XZNUGFQTQHRASN-XQENGBIVSA-N
References
1. Almabruk KH, Chang JH, Mahmud T. (2016)
Total Synthesis of (±)-Isoperbergins and Correction of the Chemical Structure of Perbergin.
J Nat Prod, 79 (9): 2391-6. [PMID:27588436]
2. Kang AD, Smith KP, Eliopoulos GM, Berg AH, McCoy C, Kirby JE. (2017)
Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Diagn Microbiol Infect Dis, 88 (2): 188-191. [PMID:28341099]
3. Roch M, Sierra R, Sands K, Martins WMBS, Schrenzel J, Walsh TR, Gales AC, Andrey DO. (2021)
Vertical and horizontal dissemination of an IncC plasmid harbouring rmtB 16S rRNA methylase gene, conferring resistance to plazomicin, among invasive ST258 and ST16 KPC-producing Klebsiella pneumoniae.
J Glob Antimicrob Resist, 24: 183-189. [PMID:33373732]
4. Sheng Y, Lam PW, Shahab S, Santosa DA, Proteau PJ, Zabriskie TM, Mahmud T. (2015)
Identification of Elaiophylin Skeletal Variants from the Indonesian Streptomyces sp. ICBB 9297.
J Nat Prod, 78 (11): 2768-75. [PMID:26510047]
5.  Juvabis Announces Positive Phase 1 Results of EBL-1003 in the Innovative Medicines Initiative’s ENABLE Consortium.
Accessed on 23/02/2023. Modified on 23/02/2023. AMR Conference, https://amr-conference.com/news/juvabis-announces-positive-phase-1-results-of-ebl-1003-in-the-innovative-medicines-initiatives-enable-consortium/